AL (ArchLoot) fluctuates 117.9% in 24 hours: low liquidity trading triggers drastic price volatility
Bitget Pulse2026/05/13 03:22Volatility Overview
AL (ArchLoot) rebounded from a low of $0.003213 to a high of $0.007 within the past 24 hours, currently trading at $0.005127, with a price fluctuation of 117.9%. Trading volume significantly expanded to approximately $3.88 million - $11.2 million, up 229% compared to the previous period, but overall liquidity remains low.
Brief Analysis of Anomaly Causes
- Low-liquidity trading dominated: Small capital inflows are amplified in thin liquidity markets, resulting in sharp price swings without apparent external catalysts.
- No official announcements, notable on-chain events, or whale activity: Platforms like Dune/Nansen did not detect any large transfers or contract interactions in the past 24 hours.
Market View and Outlook
Mainstream market sentiment remains cautious. Discussion and attention on the X platform community are sparse; analysts warn that low liquidity is vulnerable to manipulation. Short-term volatility may persist, with possible retracement to the $0.003 support level. It is advised to monitor whether trading volume further expands.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
$400 Billion Pharma “Merger of the Century”: AstraZeneca in Merger Talks with Bristol-Myers Squibb
If the deal is completed, it will create a pharmaceutical giant with a market capitalization close to $400 billion, making it the fourth-largest pharmaceutical company in the world and one of the biggest mergers and acquisitions in the history of the pharmaceutical industry. AstraZeneca aims to fill the gap in its target of $80 billion in revenue by 2030, while Bristol Myers Squibb is eager to address the crisis caused by the expiration of core drug patents.
ALT5 Sigma transfers $99.7M WLFI as unrealized losses hit $853M: What’s next?
Semiconductor's "one-sided bull" collapses! Philadelphia Semiconductor Index plunges 21% in one month, AI spending boom faces trust crisis
The unilateral semiconductor rally that has dominated the stock market so far this year is rapidly unraveling, causing anxious volatility—as investors grow increasingly concerned that the AI spending frenzy may not be sustainable.
ADA Price Jumps 10% While Cardano Turns Toward Its Next Big Upgrade Era
Crypto prices
More
